METiS Pharma to Showcase AI-Driven mRNA Delivery Innovations at BIOCHINA 2025 in Suzhou

Mar 07, 2025 11:20 CST Updated 11:20

METiS TechBio

AI-Driven Drug Formulation Developer

BIOCHINA 2025 will be held inMarch 13-15InSuzhou International Expo CenterGrand Opening! This year's exhibition is expected to attract 850 speakers and 30,000 attendees from related institutions in research, industry, investment, clinical, government and other fields, jointly witnessing the latest development achievements and future trends in the biotechnology industry.

This conference,As the planner of the mRNA new technology breakthrough special topic,METiS TechBio Co-Founder & CEO Dr. Caida LaiWill Deliver a Keynote Speech on "AI Technology Empowering mRNA Drug Development"，Deeply Analyzing the Cutting-edge Applications of AI in LNP Delivery Technology. METiS TechBio has developed the METiS LipidLM lipid language model and the PhatGPT lipid generation model, utilizing AI + high-throughput screening to discover BIC and FIC LNP delivery systems.Enhance mRNA delivery efficiency 20 times beyond the industry standard, and expand to complex targeted deliveries such as the brain, muscles, and tumors, supporting precise and efficient delivery of mRNA vaccines and therapeutic drugs.

The mRNA New Technology Breakthrough Session will also feature a high-level roundtable forum, hosted by Dr. Lai Cai-da, with distinguished guests including Yuan Zhe-fan, founder of Starry Wisdom Innovation, Zuo Chi-jian, co-founder and deputy general manager of Coremed, and Professor Wang Ze-feng, chair professor at Southern University of Science and Technology and founder of Huanma Biomedical Sciences.Jointly explore how mRNA new technologies drive industrial development.

mRNA New Technology Breakthrough Special Agenda:

This conference will bring together industry experts in the fields of mRNA and delivery to explore future development opportunities. Colleagues from the industry are welcome to attend and exchange ideas!Click on the image to jump and view the detailed schedule:

Learn More About METiS TechBio

METiS TechBio Scientist Discusses miRNA, RNAi, and mRNA Technologies

From AI Dominating the Nobel Prize to Industry Trends: METiS TechBio's Reflections and Forecasts

METiS TechBio 2024 Year-End Review | AI Wave Surges, RNA Opens a New Chapter